About CiToxLAB
CiToxLAB is a Healthcare company based in Evreux (France) founded in 1969, and was acquired by Charles River Laboratories in February 2019. In vivo and in vitro toxicology services are provided globally. CiToxLAB has completed 3 acquisitions, including AccelLAB, Solvo Biotechnology and Xenometrics. Its focus areas include Biopharma Outsourcing, CRO, Preclinical Studies and Diversified.
Company details
CiToxLAB is a global CRO specializing in providing in vivo and in vitro toxicology services. CiToxLAB was formed by the merger of CiT Health and Safety Research Laboratories and LAB Research Inc. The company provides comprehensive services in toxicology and safety pharmacology, ADME, environmental risk assessment, clinical and non-clinical bioanalysis, clinical pathology, immunology and genomics, and other laboratory services. The company claims expertise in Infusion, Inhalation, Ocular routes to toxicology testing, as well as dermal studies and surgical implantation of medical devices.
- Headquarters Evreux, France
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website citoxlab.com
- Social LinkedIn X Facebook
- Acquired by Charles River Laboratories (Feb 2019)
- Investors
- Investments & AcquisitionsAccelLAB
& 2 more
- Acquired byCharles River Laboratories
(Feb 2019)
Investors in CiToxLAB
CiToxLAB has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Charles River Laboratories.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of drug discovery and preclinical development services | 1947 | criver.com | Wilmington, United States |
Investor details for CiToxLAB
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CiToxLAB
CiToxLAB has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include AccelLAB, Solvo Biotechnology and Xenometrics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Develops transporter assays | solvobiotech.com | Budaors, Hungary | 1999 | Mar 2018 | β’β’β’β’ | |
Non-clinical laboratory services in pharmacology and toxicology are offered. | xenometricsllc.com | Stilwell, United States | 2006 | Oct 2017 | β’β’β’β’ | |
Preclinical research services for medical devices are offered. | accellab.com | Boisbriand, Canada | 2004 | Nov 2016 | β’β’β’β’ |
Complete acquisition details for CiToxLAB
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of CiToxLAB
5 dated milestones of CiToxLAB across 50 years, from founding to its latest funding, stage changes and deals.
- Founded CiToxLAB is founded.
- Acquisition Acquires AccelLAB.
- Acquisition Acquires Xenometrics.
- Acquisition Acquires Solvo Biotechnology.
- Exit Acquired by Charles River Laboratories.
Web traffic of CiToxLAB
Websites that share an audience with CiToxLAB (citoxlab.com).
Websites whose visitors overlap most with CiToxLAB. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bioreliance.com | 100% | 2.1K | #7,984,772 | View details | |
| qps.com | 99% | 19.2K | #1,101,936 | View details | |
midwestbioresearch.com | midwestbioresearch.com | 98% | β | ||
abtox.org | abtox.org | 98% | #3,123,946 | β | |
majer.com.pl | majer.com.pl | 69% | β | ||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 11 similar websites and full traffic analytics for CiToxLAB
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 11 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Citoxlab
Complete news archive for CiToxLAB
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CiToxLAB
CiToxLAB was founded in 1969.
CiToxLAB is headquartered in Evreux, France.
CiToxLAB is a global CRO specializing in providing in vivo and in vitro toxicology services. CiToxLAB was formed by the merger of CiT Health and Safety Research Laboratories and LAB Research Inc. The company provides comprehensive services in toxicology and safety pharmacology, ADME, environmental risk assessment, clinical and non-clinical bioanalysis, clinical pathology, immunology and genomics, and other laboratory services. The company claims expertise in Infusion, Inhalation, Ocular routes to toxicology testing, as well as dermal studies and surgical implantation of medical devices.
CiToxLAB has made 3 acquisitions, including AccelLAB, Solvo Biotechnology, and Xenometrics.
CiToxLAB has 1 investor. Key investors include Charles River Laboratories.
Yes. CiToxLAB was acquired by Charles River Laboratories in February 2019.

